Table 3.
Analysis specification | No. of studies | Study heterogeneity | Effects model | Pooled HR(95% CI) | p-Value | |
---|---|---|---|---|---|---|
I2 (%) | Pheterogeneity | |||||
CSS | ||||||
Overall | 22 | 76.5 | < 0.001 | Random | 1.37(1.23,1.53) | < 0.001 |
Geographical region | ||||||
Asian | 7 | 51.7 | 0.053 | Random | 1.34(1.12,1.59) | 0.001 |
Other regions | 15 | 80.8 | < 0.001 | Random | 1.40(1.22,1.60) | < 0.001 |
Pathological types | ||||||
ccRCC | 6 | 0 | 0.775 | Fixed | 1.34(1.15,1.55) | < 0.001 |
Other types | 16 | 81.7 | < 0.001 | Random | 1.38(1.22,1.58) | < 0.001 |
Staging system | ||||||
2010 AJCC | 8 | 0 | 0.981 | Fixed | 1.30(1.17,1.44) | < 0.001 |
Other system | 14 | 82.3 | < 0.001 | Random | 1.42(1.23,1.64) | < 0.001 |
No. of patients | ||||||
≥ 300 | 13 | 82 | < 0.001 | Random | 1.39(1.21,1.61) | < 0.001 |
< 300 | 9 | 15,4 | 0.301 | Fixed | 1.33(1.16,1.51) | < 0.001 |
Median follow-up | ||||||
≥ 40 months | 12 | 83.3 | < 0.001 | Random | 1.36(1.16,1.60) | < 0.001 |
< 40 months | 9 | 30.2 | 0.177 | Fixed | 1.33(1.16,1.51) | < 0.001 |
OS | ||||||
Overall | 17 | 57.6 | 0.002 | Random | 1.29(1.20,1.40) | < 0.001 |
Geographical region | ||||||
Asian | 9 | 30.2 | 0.177 | Fixed | 1.38(1.25,1.51) | < 0.001 |
Other regions | 8 | 58.6 | 0.017 | Random | 1.20(1.09,1.34) | < 0.001 |
Pathological types | ||||||
ccRCC | 8 | 48.8 | 0.057 | Random | 1.33(1.19,1.49) | < 0.001 |
Other types | 9 | 62.7 | 0.006 | Random | 1.26(1.13,1.41) | < 0.001 |
Staging system | ||||||
2010 AJCC | 10 | 63.6 | 0.003 | Random | 1.30(1.17,1.44) | < 0.001 |
Other system | 7 | 53.1 | 0.046 | Random | 1.30(1.14,1.47) | < 0.001 |
No. of patients | ||||||
≥ 300 | 8 | 67.5 | 0.003 | Random | 1.25(1.12,1.39) | < 0.001 |
< 300 | 9 | 29.2 | 0.185 | Fixed | 1.35(1.22,1.49) | < 0.001 |
Median follow-up | ||||||
≥ 40 months | 13 | 62.6 | 0.001 | Random | 1.27(1.16,1.39) | < 0.001 |
< 40 months | 4 | 0 | 0.412 | Fixed | 1.37(1.20,1.56) | < 0.001 |
RFS | ||||||
Overall | 9 | 35.6 | 0.133 | Fixed | 1.55(1.39,1.72) | < 0.001 |
Geographical region | ||||||
Asian | 6 | 42.7 | 0.12 | Fixed | 1.48(1.31,1.66) | < 0.001 |
Other regions | 3 | 0 | 0.684 | Fixed | 1.87(1.41,2.37) | < 0.001 |
Pathological types | ||||||
ccRCC | 4 | 0 | 0.541 | Fixed | 1.61(1.40,1.86) | < 0.001 |
Other types | 5 | 57.5 | 0.051 | Random | 1.46(1.25,1.71) | < 0.001 |
Staging system | ||||||
2010 AJCC | 5 | 54 | 0.069 | Random | 1.48(1.31,1.69) | < 0.001 |
Other system | 4 | 0 | 0.483 | Fixed | 1.69(1.40,2.04) | < 0.001 |
No. of patients | ||||||
≥ 300 | 4 | 0 | 0.702 | Fixed | 1.57(1.35,1.83) | < 0.001 |
< 300 | 5 | 63.4 | 0.027 | Random | 1.52(1.32,1.76) | < 0.001 |
Median follow-up | ||||||
≥ 40 months | 6 | 0 | 0.758 | Fixed | 1.62(1.43,1.84) | < 0.001 |
< 40 months | 3 | 75.3 | 0.018 | Random | 1.39(1.16,1.68) | 0.001 |
PFS | ||||||
Overall | 5 | 32.9 | 0.202 | Fixed | 1.31(1.17,1.46) | < 0.001 |
Pathological types | ||||||
ccRCC | 2 | 67.8 | 0.078 | Random | 1.44(1.20,1.71) | < 0.001 |
Other types | 3 | 0 | 0.6 | Fixed | 1.23(1.07,1.41) | 0.004 |
Staging system | ||||||
2010 AJCC | 2 | 76.3 | 0.04 | Random | 1.35(1.18,1.54) | < 0.001 |
Other system | 3 | 0 | 0.582 | Fixed | 1.22(1.01,1.48) | 0.036 |